Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells. 1998

H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
Dept of Medicine & Physical Therapy, University of Tokyo, School of Medicine, Japan.

Erythromycin and its fourteen-member macrolide analogues have attracted attention for their efficacy in bronchial asthma. However, their mechanisms of action remain unclear. We evaluated the effects of the macrolide antibiotics on endothelin-1 (ET-1) expression in normal and transformed human bronchial epithelial cells, one of the sources of this potent bronchoconstrictor important in the pathogenesis of asthma. Human bronchial epithelial cells were obtained from the resected bronchi, and the effect of several antimicrobial and antiasthmatic drugs on the production and messenger ribonucleic acid (mRNA) levels of ET-1 was evaluated. Bronchoepithelial cells were also isolated from the mucosa of asthmatic patients under fibreoptic bronchoscopy, and the modulating effects of the drugs were studied. Erythromycin and clarithromycin uniquely suppressed mRNA levels as well as the release of ET- at therapeutic and non-cytotoxic concentrations (percentage inhibition of ET-1 protein release: 26.4+/-5.22% and 31.2+/-7.45%, respectively, at 10(-6) M). Furthermore, erythromycin and clarithromycin inhibited ET-1 expression in bronchoepithelial cells from patients with chronic, stable asthma. A glucocorticosteroid, dexamethasone, also inhibited ET-1 expression. In contrast, theophylline, salbutamol and FK506 had no effect on ET-1 production. Our findings demonstrated that these fourteen-member macrolide antibiotics had an inhibitory effect on endothelin-1 expression in human bronchial epithelial cells. Moreover, this new mode of action may have some relevance to their clinical efficacy in bronchial asthma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
March 1996, Biochemical and biophysical research communications,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
December 2001, The Japanese journal of antibiotics,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
November 2004, Journal of cardiovascular pharmacology,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
January 2013, Pharmacology,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
September 2001, American journal of respiratory cell and molecular biology,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
January 2015, Pharmacology,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
October 2004, Current opinion in allergy and clinical immunology,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
February 2000, The Journal of allergy and clinical immunology,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
January 2008, Respiration; international review of thoracic diseases,
H Takizawa, and M Desaki, and T Ohtoshi, and S Kawasaki, and T Kohyama, and M Sato, and J Nakajima, and M Yanagisawa, and K Ito
November 2016, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!